Search Results for "Daptomycin Causing Hemolytic Anemia"
Original Source: Daptomycin as successful treatment for a refractory case of prosthetic valve endocarditis because of methicillin-sensitive Staphylococcus aureus.
We report on an intravenous drug user who presented with methicillin-sensitive Staphylococcus aureus bacteremia and endocarditis of a prosthetic tricuspid valve, with a 4-cm vegetation refractory to standard antibiotic treatment. The patient responded to intravenous daptomycin therapy clinically and microbiologically, despite an absence of surgical intervention.
Matching Channels
Warm antibody hemolytic anemia
Thrombotic Thrombocytopenic Purpura TTP and HemolyticUremic Syndrome HUS
Hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are microangiopathic disorders—that is, they are characterized by abnormalities (chiefly blood clots) that occur w...
Matching News
Malaria drug association with hemolytic anemia unclear
(HealthDay)—Artesunate, a drug used in the treatment of severe malaria, may or may not be associated with hemolytic anemia, so the U.S. Centers for Disease Control and Prevention recommends close mo...
Early Daptomycin Use May Help in MRSA Bacteremia
Early daptomycin use may improve outcomes in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia when the vancomycin minimal inhibitory concentration (MIC) is above 1 mcg/L. Reuters Health...
Methods Evaluated for Autoimmune Hemolytic Anemia Diagnosis
The use of both the gel test and flow cytometry techniques in the detection of red blood cell-bound immunoglobulin...
Daptomycin treats S. aureus bacteremia without nephrotoxicity
NEW YORK (Reuters Health) - Daptomycin, with or without beta-lactams, controls Staphylococcus aureus bacteremia without worsening renal dysfunction, registry data suggest.
Hemolytic Anemia After Treatment With Artesunate for Malaria
Are there certain side effects that clinicians should be aware of when treating patients with malaria with artesunate? Morbidity & Mortality Weekly Report
Trius patent allowed for tedizolid-daptomycin bacteremia combo
On the eve of Trius Therapeutics' pursuit of US FDA approval for the antibiotic tedizolid phosphate, the San Diego-based company continues to expand the potential market for its drug candidate with p...
Astellas, GSK In Race For Anemia Drug With High-Altitude Feeling
Astellas Pharma and GlaxoSmithKline are in a race to develop a new type of drug for treating anemia by causing the body to feel it is at a high altitude, a pill considered worth about $8 billion a yea...
The Anemia Partnering 2007-2012 provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analys...
Matching PubMed Articles
Immune hemolytic anemia associated with drug therapy.
Drug-induced immune hemolytic anemia (DIIHA) is rare; it can be mild or associated with acute severe hemolytic anemia (HA) and death. About 125 drugs have been implicated as the cause. The HA can be c...
Severe autoimmune hemolytic anemia with renal neoplasm.
Autoimmune hemolytic anemia is a type of hemolytic anemia characterized by autoantibodies directed against red blood cells shortening their survival. When autoimmune hemolytic anemia is secondary to a...
INTRODUCTION: Malignancy is often associated with hematological disorders, but rarely is the diagnosis of malignancy secondary to the diagnosis of microangiopathic hemolytic anemia and thrombocytopeni...
Tolosa-Hunt Syndrome in a Patient with Autoimmune Hemolytic Anemia.
ABSTRACT Tolosa-Hunt syndrome is a steroid responsive painful opthalmoplegia due to a nonspecific inflammation of the cavernous sinus. Autoimmune hemolytic anemia is caused by antibodies directed agai...
A Severe Case of Cefoxitin-Induced Immune Hemolytic Anemia.
Drug-induced immune hemolytic anemia is a rare but underdiagnosed and potentially fatal condition. We report a case of severe hemolytic anemia induced by cefoxitin in a 45-year-old woman admitted with...
